ophthalmologyadvisor32 分钟
Dexamethasone Implant Improves Outcomes vs Brolucizumab For Some With DME
Dexamethasone implants improve visual and anatomical outcomes better than brolucizumab in patients with both DME and hyperreflective intraretinal dots.